The journey from a promising biological target to a life-saving therapeutic is fraught with challenges, where the quality and reliability of experimental data can mean the difference between a breakthrough and a dead end. For years, the scientific community has relied on established methods to
The intricate web of biochemical reactions occurring within our cells every second represents a foundational, yet often overlooked, frontier in medical science. Metabolism assays, the analytical tools designed to measure these vital processes, are emerging as a linchpin in the future of healthcare,
A critical question is now reshaping how the medical community approaches patient care after a diagnosis, challenging a long-held assumption that the rules of disease prevention also apply to disease survival. For decades, research has focused intensely on identifying risk factors to help healthy
The future of medicine is no longer being synthesized exclusively in a chemistry lab; it is being grown, cultivated, and programmed within the very biological systems it is designed to heal. A transformative class of treatments known as biologics is fundamentally altering the therapeutic landscape,
Recent turmoil within the FDA has ignited a fierce debate over the future of vaccine regulation in the United States. A senior official’s internal memo, which critics describe as a break from long-standing scientific norms, has proposed a radical overhaul of how vaccines are approved and monitored.
In the intricate landscape of South Korean corporate governance, a critical legislative proposal aimed at empowering shareholders has inadvertently triggered a wave of defensive maneuvers by some of the nation's leading pharmaceutical companies. As lawmakers debate a reform that would force
